Successful treatment of pancreatitis caused by L-asparaginase in clinical practice

QR Code

Successful treatment of pancreatitis caused by L-asparaginase in clinical practice

Treatment intensification of acute lymphoblastic leukemia in children with L-asparaginase (L-ASP) improves therapy effectiveness and shows high survival rates. The unique biological properties of this enzyme make it possible to suppress tumor blasts proliferation by reducing blood asparagine concent...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yu. S. Korkina, M. A. Shervashidze, T. T. Valiev, N. A. Batmanova, T. R. Panferova
Format:	Article
Language:	Russian
Published:	ABV-press 2024-01-01
Series:	Онкогематология
Subjects:	l-asparaginase acute lymphoblastic leukemia pancreatitis children
Online Access:	https://oncohematology.abvpress.ru/ongm/article/view/903
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Expert recommendations for pancreatitis/pancreatic necrosis treatment after L-asparaginase in children with acute lymphoblastic leukemia
by: T. T. Valiev, et al.
Published: (2024-04-01)

Toxicity of L-asparaginase drugs in acute lymphoblastic leukemia treatment
by: T. T. Valiev
Published: (2023-09-01)

L-asparaginase: New about Well-Known Drug
by: Yuliya S. Korkina, et al.
Published: (2021-07-01)

Optimization of native E. coli-asparaginase therapy in standard risk-group children with acute lymphoblastic leukemia treated by the ALL-MB 2002 protocol
by: M. Yu. Goroshkova, et al.
Published: (2022-11-01)

Risk factors and outcome of asparaginase-associated pancreatitis in pediatric acute lymphoblastic leukemia
by: Seham Hassan, et al.
Published: (2025-06-01)

Native and pegylated forms of L-asparaginase: the assessment of effectiveness and toxicity in acute lymphoblastic leukemia treated with Berlin–Frankfurt–Munster (BFM) protocol
by: M. A. Shervashidze, et al.
Published: (2024-12-01)

Pharmacokinetics of Pegaspargase with a Limited Sampling Strategy for Asparaginase Activity Monitoring in Children with Acute Lymphoblastic Leukemia
by: Cristina Matteo, et al.
Published: (2025-07-01)

Catastrophic asparaginase-induced cerebral and systemic thrombosis in a young female with T-cell lymphoblastic lymphoma: A case report & literature review
by: Shihab Ahmed Ibrahim Ahmed, et al.
Published: (2025-01-01)

Probing the Active Site of Class 3 L-Asparaginase by Mutagenesis: Mutations of the Ser-Lys Tandems of ReAV
by: Kinga Pokrywka, et al.
Published: (2025-06-01)

Pediatric acute lymphoblastic leukemia treatment protocols improvement: emphasis on minimal residual disease
by: M. A. Shervashidze, et al.
Published: (2020-10-01)

Toxicity assessment of acute lymphoblastic leukemia treatment protocol ALL IC-BFM 2002
by: T. T. Valiev, et al.
Published: (2022-07-01)

Clinical and molecular-biologic features of infant acute leukemia
by: Y. S. Korkina, et al.
Published: (2022-04-01)

Ocular involvement in pediatric patients with acute leukemia relapse: points of diagnosis and treatment
by: G. A. Radzhabova, et al.
Published: (2025-03-01)

The role of high-dose methotrexate in T-cell acute lymphoblastic leukemia treatment: multicenter study results of ALL IC-BFM 2002 protocol
by: T. T. Valiev, et al.
Published: (2024-12-01)

Extraction and purification of L-Asparaginase II from local isolate of Proteus vulgaris
by: Baghdad Science Journal
Published: (2011-03-01)

Hemostasis defects correction in children with acute lymphoblastic leukemia
by: A. S. Roshik, et al.
Published: (2022-11-01)

Acute lymphoblastic leukemia with eosinophilia: diagnostic and treatment features
by: O. D. Gurieva, et al.
Published: (2025-05-01)

Purification and characterization of L-asparaginase produced from Bacillus sp.
by: Sahar I. H., et al.
Published: (2023-12-01)

Antileukemic impact of glucocorticoid use in acute lymphoblastic leukaemia treatment
by: Meri A. Shervashidze, et al.
Published: (2023-08-01)

Comparative methodological studies of L-asparaginase encapsulation into erythrocytes
by: D. V. Borsakova, et al.
Published: (2018-10-01)

Errors in the diagnosis of acute leukemia in infants (clinical observations)
by: G. A. Kharchenko, et al.
Published: (2023-02-01)

Features of children temperament with acute lymphoblastic leukemia
by: N. A. Kornetov, et al.
Published: (2016-02-01)

Comparative efficacy of acute lymphoblastic leukemia treatment of children in St.-Petersburg using two COALL-92 versions
by: E. G. Boychenko, et al.
Published: (2014-07-01)

Comparative analysis of therapy results in children with acute lymphoblastic leukemia receiving ALL-MB-2002 and COALL-St.Petersburg-92 protocols
by: E. G. Boychenko, et al.
Published: (2022-11-01)

Obesity in children with acute lymphoblastic leukemia in remission: the evaluation of causes, hidden nutritional deficiency and the experience of its correction by using artificial enteral nutrition
by: A. Yu. Vashura, et al.
Published: (2021-11-01)

Clinical case of successful treatment of COVID-19 infection manifested with B-cell acute lymphoblastic leukemia
by: T. N. Aleksandrova, et al.
Published: (2022-01-01)

False-Positive and False-Negative MRD Results in Children with Acute Lymphoblastic Leukemia: Navigating Between Scylla and Charybdis (Brief Review and Clinical Experience)
by: Yulia S. Korkina, et al.
Published: (2025-06-01)

FEATURES OF IMMUNE CELLS IN ACUTE LYMPHOBLASTIC LEUKEMIA
by: O. V. Smirnova, et al.
Published: (2014-07-01)

FUNCTIONAL ACTIVITY OF NEUTROPHILS IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA
by: T. G. Kadricheva, et al.
Published: (2014-07-01)

COVID-19 in patients with acute leukemia: 3 years' experience of pandemic
by: T. S. Chudnova, et al.
Published: (2024-01-01)

Possibilities of rehabilitation treatment of children with lymphoblastic leukemia (literary review)
by: S.V. Lukashchuk, et al.
Published: (2021-12-01)

STAGE-DEPENDENT IMMUNOPATHOGENETIC FEATURES OF ACUTE NONLYMPHOBLASTIC AND ACUTE LYMPHOBLASTIC LEUKEMIA
by: O. V. Smirnova, et al.
Published: (2014-07-01)

Pharmacoeconomic analysis of treatment of children with acute lymphoblastic leukemia according to ALL-MB-2002 protocol
by: N. V. Miga, et al.
Published: (2022-11-01)

Complex rehabilitation of children with long-term acute lymphoblastic leukemia remission
by: I. V. Tkachenko, et al.
Published: (2022-11-01)

Immunophenotypic features of bone marrow tumor cell in Burkitt lymphoma/leukemia: B-lineage acute lymphoblastic leukemia diagnostics opportunities
by: I. A. Demina, et al.
Published: (2017-04-01)

HETEROGENEITY OF CHILDHOOD B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (EGIL SUBTYPE BIV)
by: I. A. Demina, et al.
Published: (2018-02-01)

IMMUNE PROFILE AND ENZYMES ACTIVITY STATE IN BLOOD LYMPHOCYTES IN PATIENTS OF DIFFERENT STAGES ACUTE LYMPHOBLAST LEUKEMIA
by: O. V. Smirnova, et al.
Published: (2014-07-01)

RUSSIAN-BELARUSIAN MULTICENTER GROUP STANDARD GUIDELINES FOR CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA FLOW CYTOMETRIC DIAGNOSTICS
by: I. A. Novikova, et al.
Published: (2018-05-01)

Immunophenotypic investigation of infant acute lymphoblastic leukemia
by: A. M. Popov, et al.
Published: (2014-07-01)

Results of external quality control study in flow cytometric acute lymphoblastic leukemia diagnostics
by: A. M. Popov, et al.
Published: (2016-10-01)